Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
0
Listed Dossiers
Annual Reports
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bosutinib Hydrate
2. 918639-08-4
3. Ski-606 Monohydrate
4. Bosutinib.h2o
5. Bosutinib (hydrate)
6. 844zje6i55
7. Bosutinib Hydrate (jan)
8. 3-quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-, Hydrate (1:1)
9. 4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile;hydrate
10. Bosutinib Hydrate [jan]
11. Bosutinib (as Monohydrate)
12. 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile Monohydrate
13. 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile--water (1/1)
14. Bosutinibhydrate
15. Unii-844zje6i55
16. Bosulif (tn)
17. Schembl2887945
18. Chebi:68533
19. Dtxsid20238722
20. Amy16532
21. Bcp17036
22. Hy-10158a
23. Akos027326604
24. Ac-30573
25. Bosutinib Monohydrate [orange Book]
26. Cs-0019907
27. Bosutinib (as Monohydrate) [ema Epar]
28. D09728
29. A900109
30. Q27137001
31. 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl) Propoxy]-3-quinolinecarbonitrile Monohydrate
32. 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile Monohydrate
Molecular Weight | 548.5 g/mol |
---|---|
Molecular Formula | C26H31Cl2N5O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 9 |
Exact Mass | 547.1753099 g/mol |
Monoisotopic Mass | 547.1753099 g/mol |
Topological Polar Surface Area | 83.9 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 734 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Bosulif |
PubMed Health | Bosutinib (By mouth) |
Drug Classes | Antineoplastic Agent |
Active Ingredient | Bosutinib monohydrate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 100mg base; eq 500mg base |
Market Status | Prescription |
Company | Wyeth Pharms |
2 of 2 | |
---|---|
Drug Name | Bosulif |
PubMed Health | Bosutinib (By mouth) |
Drug Classes | Antineoplastic Agent |
Active Ingredient | Bosutinib monohydrate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 100mg base; eq 500mg base |
Market Status | Prescription |
Company | Wyeth Pharms |
Bosulif is indicated for the treatment of adult patients with:
- newlydiagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukaemia (Ph+ CML).
- CP, accelerated phase (AP), and blast phase (BP) Ph+ CML previously treated with one or more tyrosine kinase inhibitor(s) [TKI(s)] and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
33
PharmaCompass offers a list of Bosutinib Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bosutinib Monohydrate manufacturer or Bosutinib Monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bosutinib Monohydrate manufacturer or Bosutinib Monohydrate supplier.
PharmaCompass also assists you with knowing the Bosutinib Monohydrate API Price utilized in the formulation of products. Bosutinib Monohydrate API Price is not always fixed or binding as the Bosutinib Monohydrate Price is obtained through a variety of data sources. The Bosutinib Monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 918639-08-4 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 918639-08-4, including repackagers and relabelers. The FDA regulates 918639-08-4 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 918639-08-4 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 918639-08-4 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 918639-08-4 supplier is an individual or a company that provides 918639-08-4 active pharmaceutical ingredient (API) or 918639-08-4 finished formulations upon request. The 918639-08-4 suppliers may include 918639-08-4 API manufacturers, exporters, distributors and traders.
click here to find a list of 918639-08-4 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 918639-08-4 DMF (Drug Master File) is a document detailing the whole manufacturing process of 918639-08-4 active pharmaceutical ingredient (API) in detail. Different forms of 918639-08-4 DMFs exist exist since differing nations have different regulations, such as 918639-08-4 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 918639-08-4 DMF submitted to regulatory agencies in the US is known as a USDMF. 918639-08-4 USDMF includes data on 918639-08-4's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 918639-08-4 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 918639-08-4 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 918639-08-4 Drug Master File in Japan (918639-08-4 JDMF) empowers 918639-08-4 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 918639-08-4 JDMF during the approval evaluation for pharmaceutical products. At the time of 918639-08-4 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 918639-08-4 suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 918639-08-4 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 918639-08-4 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 918639-08-4 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 918639-08-4 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 918639-08-4 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 918639-08-4 suppliers with NDC on PharmaCompass.
918639-08-4 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 918639-08-4 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 918639-08-4 GMP manufacturer or 918639-08-4 GMP API supplier for your needs.
A 918639-08-4 CoA (Certificate of Analysis) is a formal document that attests to 918639-08-4's compliance with 918639-08-4 specifications and serves as a tool for batch-level quality control.
918639-08-4 CoA mostly includes findings from lab analyses of a specific batch. For each 918639-08-4 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
918639-08-4 may be tested according to a variety of international standards, such as European Pharmacopoeia (918639-08-4 EP), 918639-08-4 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (918639-08-4 USP).